A retrospective chart review to investigate clinical remission in patients with severe asthma treated with biologics in the United Kingdom National Health Service

Trial Identifier: D2287R00189
Sponsor: AstraZeneca
Start Date: February 2024
Primary Completion Date: August 2024
Study Completion Date: August 2024
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UK Birmingham, UK
UK London, UK
UK Manchester, UK
UK Southampton, UK